1-3 of 3
Yoon Young Cho, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Sang Kyun Sohn, MD PhD, Joon Ho Moon, MD PhD, Ahn Jae Sook, MD, PhD, Hyeoung Joon Kim, MD PhD, Moo kon Song, MD, PhD, Ho-Jin Shin, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Young Don Joo, MD PhD, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, MD PhD, Sung Hwa Bae
Journal: Blood
Blood (2014) 124 (21): 3255.
https://doi.org/10.1182/blood.V124.21.3255.3255
Published: 2014
Journal Articles

Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.

Yee Soo Chae, MD, Sang Kyun Sohn, MD, PhD, Jong Gwang Kim, MD, PhD, Yoon Young Cho, MD, Joon Ho Moon, MD, Byung Min Ahn, MD, Shi Nae Kim, MD
Journal: Blood
Blood (2007) 110 (11): 4258.
https://doi.org/10.1182/blood.V110.11.4258.4258
Published: 2007
Journal Articles

Treatment Outcomes for Imatinib Mesylate and Allogeneic Stem Cell Transplantation in Patients with CML Based on RQ-PCR, and the Efficacy of Dose Escalation of Imatinib Mesylate in Patients with Cytogenetic or Hematologic Resistance.

Sang Kyun Sohn, MD, Yoon Young Cho, MD, Byung Min Ahn, MD, Yee Soo Chae, MD, Jong Gwang Kim, MD, Joon Ho Moon, MD
Journal: Blood
Blood (2006) 108 (11): 4762.
https://doi.org/10.1182/blood.V108.11.4762.4762
Published: 2006